Clinical trials
Terminated Phase 2 Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| Ainos, Inc. (f/k/a Amarillo Biosciences Inc. | 1 |
| Amgen | 1 |
| Aptabio Therapeutics, Inc. | 1 |
| Lung Biotechnology PBC | 1 |
| Michael M. Pham | 1 |
| Pliant Therapeutics, Inc. | 1 |
| PureTech | 1 |
| The University of Queensland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 12 |
| Idiopathic Pulmonary Fibrosis | 6 |
| Lung Diseases, Interstitial | 5 |
| Fibrosis | 3 |
| COVID-19 | 2 |
| Scleroderma, Systemic | 2 |
| Chronic Cough | 1 |
| Cough | 1 |
| Dyskeratosis Congenita | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.